|
|
Article: Cross Atlantic Commodities Inc Signs Agreement To Market Snorenz.
- Article from:
- Biotech Week
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Cross Atlantic Commodities, Inc. (CXAC.PK), a successful manufacturer of specialty health and beauty products, announced signing a distribution agreement with the holders of the Snorenz patent. Snorenz[R] is a nationally well known snoring product (see also Cross Atlantic Commodities, Inc.).
"We have done our homework on Snorenz[R] and are very excited about the research that the previous company has done and the size of the snoring category", states Jorge Bravo President / CEO. In 2002, the Company completed a double blind study at Northwestern Hospital's Sleep Center in Atlanta, GA, under the direction ...